canakinumab
novartis
['canakinumab', 'canopy-a']
can an anti-inflammatory approach prevent recurrence? unfortunately in canopy-a adjuvant canakinumab after surgery did not work, with no suggestion of benefit, although fortunately not too many side effects. #esmo2022. more canopy study results awaited. 
Associate Professor and Medical Oncologist at University of Ottawa, Past President of Lung Cancer Canada, and a cricket fan!